Story
Fosun Pharma Repurchases 72,000 Shares for HK$1.27 Million

Fosun Pharmaceutical (Group) Co., Ltd. (02196.HK) has executed a share buyback on the Hong Kong Stock Exchange, purchasing its own stock for a total of HK$1.2695 million (approximately $162,000). The transaction was detailed in a market filing on September 24, 2026.
Details of the Transaction
According to the disclosure reported by Zhitong Finance, the Chinese healthcare company repurchased a total of 72,000 shares in the open market. The total expenditure of HK$1.2695 million implies an average purchase price of approximately HK$17.63 per share.
Context for Investors
AdShare repurchase programs are a common corporate finance tool used to return capital to shareholders. By reducing the number of shares in circulation, these programs can potentially increase a company's earnings per share (EPS) and are often interpreted by the market as a sign of management's confidence that the stock is undervalued.
This buyback represents a deployment of the company's capital. Investors and market analysts often monitor such activities to gauge a company's financial health and its board's perspective on the firm's current market valuation and future outlook.
Read next
More on Stocks
FTC Orders Walmart, Uber, Delta to Disclose Data on Personalized Pricing
The U.S. Federal Trade Commission is demanding nine major companies, including leading retail, travel, and gig economy firms, to provide information on how they use consumer data for setting individual prices and wages.

Google Launches Gemini 4 Carbon AI Model to Bolster Cybersecurity Capabilities
Alphabet's Google has unveiled Gemini 4 Carbon, its latest AI model specifically designed for advanced cybersecurity tasks like vulnerability detection and secure code generation. The launch escalates competition with rivals OpenAI and Anthropic in the enterprise AI market.

Oracle Shares Surge After Unveiling $225 Billion Revenue Target for 2030
Oracle stock rose sharply after the company presented a long-term financial outlook targeting at least $225 billion in annual revenue by fiscal 2030, driven by its expanding AI infrastructure business.

DOJ Scrutinizes Nvidia's $12.9B Hugging Face Deal Amid Broader Antitrust Probe, Sources Say
The U.S. Department of Justice is reportedly examining Nvidia's planned $12.93 billion acquisition of AI platform Hugging Face as part of a wider, ongoing antitrust investigation into the chipmaker's market conduct.